The stairway: a novel behavioral test detecting sensomotoric stroke deficits in rats.

New therapeutic concepts of cell and tissue replacement therapies have been introduced in treatment of neurological disorders which require robust and sensitive sensomotoric behavioral diagnostic test systems for experimental research. However, most test arrays available are either expensive and/or sensitive to environmental disturbances. Moreover, an extensive training phase for experimental animals is often required by conventional tests to get reproducible data. In this study, we describe a new test array, the Stairway, that is robust, cost-effective, and needs only a minimum training phase. Its efficiency is evaluated in comparison to the well-established RotaRod and modified neurological severity score. Stroke was induced by middle cerebral artery occlusion. Human umbilical cord blood transplantation (n = 18) was performed 24 h after stroke by intravenous injection of suspended cells in comparison to control injections (n = 18), while behavioral assessment was carried out continuously for 29 days. Furthermore, development of lesions was monitored by magnetic resonance imaging. The results reveal the Stairway test as a simple, highly reproducible, and easy manageable test system thus reflecting therapeutic benefits precisely.

[1]  M. Chopp,et al.  Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke , 2006, Neuroscience.

[2]  F. Emmrich,et al.  Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells , 2005, German medical science : GMS e-journal.

[3]  Yi Li,et al.  Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells , 2005, Glia.

[4]  M. Chopp,et al.  Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells , 2004, Brain Research.

[5]  P. Sanberg,et al.  Central Nervous System Entry of Peripherally Injected Umbilical Cord Blood Cells Is Not Required for Neuroprotection in Stroke , 2004, Stroke.

[6]  P. Sanberg,et al.  Infusion of Human Umbilical Cord Blood Cells in a Rat Model of Stroke Dose-Dependently Rescues Behavioral Deficits and Reduces Infarct Volume , 2004, Stroke.

[7]  I. Whishaw,et al.  Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination , 2002, Journal of Neuroscience Methods.

[8]  M. Chopp,et al.  Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in Rats , 2001, Stroke.

[9]  Jieli Chen,et al.  Quantitative measurement of motor and somatosensory impairments after mild (30 min) and severe (2 h) transient middle cerebral artery occlusion in rats , 2000, Journal of the Neurological Sciences.

[10]  P. Beart,et al.  Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. , 1999, Stroke.

[11]  R. Simon,et al.  A model of proximal middle cerebral artery occlusion in rat , 1989, Journal of Neuroscience Methods.

[12]  Timothy Schallert,et al.  Seizures and recovery from experimental brain damage , 1988, Experimental Neurology.

[13]  R. Traystman Animal models of focal and global cerebral ischemia. , 2003, ILAR journal.

[14]  B. Pike,et al.  The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. , 1994, Journal of neurotrauma.